Status:
COMPLETED
Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
6-14 years
Phase:
PHASE4
Brief Summary
Prospective, parallel-group, randomized study to evaluate the compliance to the treatment of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the associati...
Detailed Description
Objectives General: To evaluate the compliance degree to the treatment of asthmatic children, according to the attention received. Specific: 1. To study asthmatic compliance to the treatment propo...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Signature of a informed consent form
- Age between 6 and 14 years old
- Diagnosis of persistent moderate or severe asthma, according to III Brazilian Consensus on Asthma Management.
- Home telephone available
- Exclusion criteria:
- Co-morbidities that may interfere with the study evaluation or that require continuous drugs, e.g., cardiopathy, gastro-esophageal reflux or diabetes.
- Continuous systemic corticosteroid use for more than seven days
- The patient has been treated or is being treated with allergen-specific immunetherapy
Exclusion
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
472 Patients enrolled
Trial Details
Trial ID
NCT01476059
Start Date
May 1 2004
End Date
December 1 2004
Last Update
June 27 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.